Dorresteijn, J
673  Ergebnisse:
Personensuche X
?
1

From reactive to proactive preventive cardiovascular risk m..:

Bongaerts, V ; Van Os, H ; Hageman, S...
European Journal of Preventive Cardiology.  31 (2024)  Supplement_1 - p. , 2024
 
?
2

Validation of models for assessing eligibility for referral..:

Moes, H. ; Buskens, E. ; Portman, A....
Parkinsonism & Related Disorders.  122 (2024)  - p. 106117 , 2024
 
?
3

Cost-utility analysis of a structured medication review com..:

Oonk, N. G. M. ; Dorresteijn, L. D. A. ; van den Berg, A. D....
European Journal of Clinical Pharmacology.  79 (2022)  2 - p. 289-297 , 2022
 
?
4

Inflammation and risk of recurrent cardiovascular events ac..:

Burger, P M ; Ridker, P ; Dorresteijn, J...
European Heart Journal.  43 (2022)  Supplement_2 - p. , 2022
 
?
5

Individual lifetime benefit from low-dose colchicine in chr..:

Burger, P ; Dorresteijn, J ; Fiolet, A...
European Heart Journal.  43 (2022)  Supplement_2 - p. , 2022
 
?
8

The effect of a structured medication review on quality of ..:

Oonk, N.G.M. ; Movig, K.L.L. ; Munster, E.M....
Contemporary Clinical Trials Communications.  13 (2019)  - p. 100308 , 2019
 
?
 
?
 
?
12

Re: Late Effects From Radiation Therapy: The Hits Just Keep..:

Aleman, B. M. P. ; de Bruin, M. L. ; Dorresteijn, L. D. A....
JNCI Journal of the National Cancer Institute.  102 (2010)  8 - p. 576-577 , 2010
 
?
14

Outbreak of severe sepsis due to contaminated propofol: les..:

Muller, A.E. ; Huisman, I. ; Roos, P.J....
Journal of Hospital Infection.  76 (2010)  3 - p. 225-230 , 2010
 
?
 
1-15
Mehr Literatur finden